tiprankstipranks
Trending News
More News >
Intellia Therapeutics Inc (NTLA)
NASDAQ:NTLA

Compare Intellia Therapeutics (NTLA) vs. Competitors

Compare
4,689 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Intellia Therapeutics
$13.05
$1.51B
-3.06
36.79%
8 Buy
10 Hold
1 Sell
Moderate Buy
Kura Oncology
$8.23
$719.63M
-3.32
-0.24%
9 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$6.42
$1.16B
-14.03
108.44%
8 Buy
0 Hold
0 Sell
Strong Buy
AbCellera Biologics
$3.50
$1.05B
-6.11
14.29%
4 Buy
1 Hold
0 Sell
Strong Buy
Janux Therapeutics Inc
$13.99
$841.47M
-8.24
-67.20%
14 Buy
2 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$16.76
$918.15M
-7.63
38.29%
9 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NTLA
Intellia Therapeutics
13.05
3.43
35.65%
KURA
Kura Oncology
8.23
-0.66
-7.42%
CMPX
Compass Therapeutics
6.42
3.30
105.77%
ABCL
AbCellera Biologics
3.52
0.31
9.66%
JANX
Janux Therapeutics Inc
13.80
-27.51
-66.59%
BCAX
Bicara Therapeutics Inc.
17.01
4.77
38.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts